MRK monthly performance report
Check MRK's monthly returns, drawdown, and seasonality trends — updated every month.
MRK monthly report
—
Key takeaways
- Merck & Co. (MRK) closed November 2026 at $147.76, down 1.18% for the month and +59.00% over the trailing 12 months.
- Year-to-date, MRK is +40.38%, outperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading +15.09% versus its 200-day moving average ($128.38), a bullish technical signal.
- Over the past three years, MRK has underperformed the S&P 500 by −27.18%, with a relative strength index reading of 84.1.
- Win rate over the trailing 39 months stands at 43.6% — 17 positive months versus 22 negative months.
Merck & Co. ended November 2026 at $147.76, posting a monthly return of −1.18%. The S&P 500 returned −0.18% over the same window, leaving relative performance at −1.00%.
The current quarter stands at +1.69% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +15.09% versus the 200-day moving average ($128.38).
Year-to-date, MRK is +40.38% against SPY +10.62%, a gap of +29.75%. The stock is currently −5.84% below its 52-week high, with maximum 3-year drawdown at −44.74%.
| Period | MRK | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.55% | −0.36% | +0.91% |
| 1 Week | +0.70% | +2.59% | −1.89% |
| 1 Month | −1.18% | −0.18% | −1.00% |
| 3 Months | +8.78% | −2.37% | +11.14% |
| 6 Months | +30.24% | +0.83% | +29.41% |
| YTD | +40.38% | +10.62% | +29.75% |
| 12 Months | +59.00% | +12.25% | +46.75% |
| 3 Years | +44.20% | +71.37% | −27.18% |
| Rank | Month | Return |
|---|---|---|
| #1 | Nov 2025 | +21.92% |
| #2 | Aug 2026 | +13.94% |
| #3 | Feb 2026 | +12.29% |
| #4 | Jan 2024 | +10.79% |
| #5 | May 2026 | +8.74% |
| Rank | Month | Return |
|---|---|---|
| #1 | Oct 2024 | −9.90% |
| #2 | May 2025 | −9.81% |
| #3 | Apr 2026 | −9.24% |
| #4 | Jul 2024 | −8.62% |
| #5 | Feb 2025 | −6.65% |
| Quarter | Return |
|---|---|
| Q3 2025 | +6.03% |
| Q4 2025 | +25.41% |
| Q1 2026 | +14.28% |
| Q2 2026 | +6.83% |
| Q3 2026 | +13.08% |
| Q4 2026 (QTD) | +1.69% |
| Year | Return |
|---|---|
| 2023 | −1.74% |
| 2024 | −8.75% |
| 2025 | +5.81% |
| 2026 | +40.38% |
| Metric | Value |
|---|---|
| 52-Week High | $156.92 (2026-08-25) |
| 52-Week Low | $87.26 (2025-11-11) |
| Current Price | $147.76 |
| 200-Day Moving Average | $128.38 |
| Price vs 200DMA | +15.09% |
| 3-Year Maximum Drawdown | −44.74% (2025-05-14) |
| Current Drawdown from 52W High | −5.84% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 84.1 |
| 3-Year Excess Return vs S&P 500 | −27.18% |
| RS Peak | 111.5 (Apr 2024) |
| RS Trough | 50.7 (Sep 2025) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was MRK's return for this report period?
MRK returned −1.18% in the latest monthly window ending 2026-11-13.
Has MRK outperformed SPY year to date?
YTD MRK: +40.38% vs SPY: +10.62%.
What is MRK's 12-month return?
+59.00% over the trailing 12 months.
Is MRK above or below its 200-day moving average?
Price is +15.09% versus 200DMA ($128.38).
What is the maximum drawdown in the 3-year window?
−44.74% on 2025-05-14.